Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

April 14, 2021
Open Access

Dalteparin as a Novel Therapeutic Agent to Prevent Diabetic Encephalopathy by Targeting Oxidative Stress and Inflammation.

Basic and Clinical Neuroscience
Motahareh ZeinivandFereshteh Golab
April 14, 2021

[Correlation analysis between type 2 diabetes and core gut microbiota].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Y XiaoS Li
April 14, 2021
Open Access

How metformin affects various malignancies by means of microRNAs: a brief review.

Cancer Cell International
Nahid AlimoradiReihaneh Fatehi
April 14, 2021

The potential impact of salivary peptides in periodontitis.

Critical Reviews in Clinical Laboratory Sciences
Christophe HirtzRui Vitorino
April 14, 2021
Open Access

Pro-inflammatory effects of DEHP in SGBS-derived adipocytes and THP-1 macrophages.

Scientific Reports
Kristina SchaedlichJana Ernst
April 14, 2021
Open Access

Early prediction keys for COVID-19 cases progression: A meta-analysis.

Journal of Infection and Public Health
Mostafa M KhodeirWaleed Al Abdulmonem
April 13, 2021
Open Access

Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells

BioRxiv : the Preprint Server for Biology
Li QiangC. J. Rosen
April 13, 2021

Molecular Boronic Acid-Based Saccharide Sensors.

ACS Sensors
George T WilliamsJohn S Fossey

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.


Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

© 2021 Meta ULC. All rights reserved